Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
As CEO, my priority is to protect the patients, the company’s long-term viability, and my own ethical integrity. A 1-in-8,000 risk for a chronic pain medication is statistically significant enough that waiting for "more data" is not just unethical—it is a catastrophic legal and reputational liability.Read the full answer
This situation represents a "bet-the-company" crisis. From a leadership perspective, the primary objective is to protect the company’s long-term viability by preserving its integrity, while mitigating the immediate financial shock. Attempting to bury this data—or "waiting for more data"—is a catastrophic error.Read the full answer